StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) stock

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)

Close on Nov 18, 2026Market cap $61.21MP/E –Yield –

Longeveron enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Longeveron's enterprise value was $53.72B on Nov 11, 2026, against $80.08B a year earlier. Over the last 5 years it ranged from $109.09M to $529.41B, with a median of $54.74B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$53.72B-12.0%
2025Dec 31, 2025$61.05B-43.6%
2024Dec 31, 2024$108.16B+38357.3%
2023Dec 29, 2023$281.25M-55.5%
2022Dec 30, 2022$631.84M-99.9%
2021Dec 31, 2021$529.41B–

More Longeveron figures

See a number that looks wrong?